Massachusetts-based Elevian, a developer of medicines focused on multiple age-related diseases, has secured $15 million in financing. Prime Movers Lab led the round.
Source: Press Release
Prime Movers Lab leads $15m round for Elevian
Massachusetts-based Elevian, a developer of medicines focused on multiple age-related diseases, has secured $15 million in financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: